Skip to main content
. 2021 Jul 3;13(13):3347. doi: 10.3390/cancers13133347

Figure 1.

Figure 1

NGF and MMP-2 levels correlated with the chondrosarcoma tumor stage. (AE) Immunohistochemistry (IHC)-stained tissue samples from chondrosarcoma patients were stained with NGF and MMP-2 antibodies then photographed and quantified. (F) Levels of NGF and MMP-2 were positively correlated. * p < 0.05 compared with the early stage (IA and IB) tumor group.